Janssen Pharmaceutica Nv

Douglas Behenna

Steven D Goldberg

Steven P Meduna

Stefan McCarver

Alexander Valdes

Xiaohua Xue

Connor L Martin

Steven Loskot

Timothy B Rhorer

John M Keith

Craig R Woods

Alexander Raymond Rovira

David A Kummer

Jennifer Diane Venable

Brock T Shireman

Dongpei Wu

Virginia M Tanis

Charlotte Pooley Deckhut

Deane Gordon

Luke E Hanna

Alexander Rovira

The present application discloses compounds having the following formula: or pharmaceutically acceptable salts thereof, wherein R, R, R, and Rare defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.

Imidazopyridazine IL-17 inhibitor compounds

The present application discloses compounds having the following formula: or pharmaceutically acceptable salts thereof, wherein R, R, R, Rand Rare defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.

Imidazopyridazines as modulators of IL-17

Growing community of inventors

San Juan Capistrano, CA, United States of America

Douglas Behenna